Aberdeen Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Buy |
108,518
+71,217
| +191% | +$9.79M | 0.03% | 495 |
|
|
2025
Q1 | $6.73M | Sell |
37,301
-19,732
| -35% | -$3.56M | 0.01% | 645 |
|
|
2024
Q4 | $8.93M | Buy |
57,033
+13,979
| +32% | +$2.19M | 0.02% | 532 |
|
|
2024
Q3 | $7.84M | Sell |
43,054
-318
| -0.7% | -$57.9K | 0.01% | 566 |
|
|
2024
Q2 | $7.96M | Buy |
43,372
+4,348
| +11% | +$798K | 0.02% | 550 |
|
|
2024
Q1 | $6.94M | Buy |
+39,024
| New | +$6.94M | 0.01% | 608 |
|